These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20806127)

  • 21. [Interference of factor VIII excess on the detection of lupus anticoagulants by the activated partial thromboplastin time].
    Guermazi S; Gorgi Y; Ayed K; Dellagi K
    Pathol Biol (Paris); 1997 Jan; 45(1):28-33. PubMed ID: 9097843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The laboratory heterogeneity of lupus anticoagulants.
    Triplett DA; Brandt JT; Maas RL
    Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a new commercial dilute prothrombin time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2008; 123(2):404-11. PubMed ID: 18495217
    [No Abstract]   [Full Text] [Related]  

  • 24. An Easy Method to Eliminate the Effect of Lupus Anticoagulants in the Coagulation Factor Assay.
    Tang N; Yin S
    Clin Lab; 2016 Jul; 62(7):1363-1365. PubMed ID: 28164630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new exogen anticoagulant with high selectivity to intrinsic pathway of coagulation.
    de Araújo RM; Vaz AF; Santos ME; Zingali RB; Coelho LC; Paiva PM; Correia MT; Oliva ML; Ferreira RS
    Thromb Res; 2011 Oct; 128(4):395-7. PubMed ID: 21752431
    [No Abstract]   [Full Text] [Related]  

  • 26. [Action of vitreous body in the blood coagulation].
    Regnault F; Larrieu MJ
    Pathol Biol (Paris); 1969 Jan; 17(1):31-7. PubMed ID: 4895968
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)].
    Follea G; Ffrench P; Trzeciak MC; Dechavanne M
    Nouv Rev Fr Hematol (1978); 1981; 23(4):203-7. PubMed ID: 7312614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupus" anticoagulant.
    Green D; Hougie C; Kazmier FJ; Lechner K; Mannucci PM; Rizza CR; Sultan Y
    Thromb Haemost; 1983 Apr; 49(2):144-6. PubMed ID: 6408752
    [No Abstract]   [Full Text] [Related]  

  • 29. Coagulation inhibitors.
    Corrigan JJ
    Am J Pediatr Hematol Oncol; 1980; 2(3):281-8. PubMed ID: 6776839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired haemophilia A: errors in the diagnosis.
    Kazmi MA; Pickering W; Smith MP; Holland LJ; Savidge GF
    Blood Coagul Fibrinolysis; 1998 Oct; 9(7):623-8. PubMed ID: 9863711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of puff adder venom on the coagulation mechanism. II. In vitro.
    Phillips LL; Weiss HJ; Christy NP
    Thromb Diath Haemorrh; 1973 Dec; 30(3):499-508. PubMed ID: 4799118
    [No Abstract]   [Full Text] [Related]  

  • 32. Testing for new oral anticoagulants with LA-resistant Russells viper venom reagents. An in vitro study.
    Exner T; Ellwood L; Rubie J; Barancewicz A
    Thromb Haemost; 2013 Apr; 109(4):762-5. PubMed ID: 23364321
    [No Abstract]   [Full Text] [Related]  

  • 33. [Modification of plasma blood coagulation factor activity by physical stress].
    Lutze G; Buhl H; Häcker R; Socha C; Socha U; Urbahn H
    Z Gesamte Inn Med; 1986 Sep; 41(18):502-5. PubMed ID: 3099480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there evidence for persistent or transient positive lupus anticoagulants according to the degree of prolongation of clotting tests?
    Devreese KM
    Thromb Res; 2008; 122(4):576-9. PubMed ID: 18304615
    [No Abstract]   [Full Text] [Related]  

  • 35. Concurrent acquired inhibitors to factor VIII and IX, a laboratory artifact: a case report.
    Doma SA; Hillarp A; Pajič T; Andoljšek D; Černelč P; Preldžnik Zupan I
    Biochem Med (Zagreb); 2016; 26(2):279-84. PubMed ID: 27346976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Circulating anticoagulants. Clinical conditions of diagnosis].
    Godeau P; Blétry O; Piette JC; Wechsler B
    Rev Med Interne; 1985 Dec; 6(5):523-41. PubMed ID: 3938557
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunologically generated circulating anticoagulants in humans.
    Edwards RL; Wakem CJ
    Surv Immunol Res; 1984; 3(1):64-9. PubMed ID: 6426006
    [No Abstract]   [Full Text] [Related]  

  • 38. The preparation of an artificial reagent for the one-stage factor VIII assay.
    Nyman D
    Thromb Diath Haemorrh; 1970 May; 23(2):206-12. PubMed ID: 5426208
    [No Abstract]   [Full Text] [Related]  

  • 39. Facts and artefacts of coagulation assays for factor Xa inhibitors.
    Haas S
    Thromb Haemost; 2010 Apr; 103(4):686-8. PubMed ID: 20174751
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibitors in young boys with haemophilia.
    Lusher JM
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.